Frontier Capital Management’s Revolution Medicines RVMD Stock Holding History

Frontier Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.7M	Sell	243,804 -186,964	-43%	-$18.9M	0.24%	151
2025 Q4	$34.3M	Buy	430,768 +307,988	+251%	+$20.2M	0.36%	96
2025 Q3	$5.73M	Sell	122,780 -3,663	-3%	-$143K	0.05%	272
2025 Q2	$4.65M	Buy	126,443 +34,832	+38%	+$1.34M	0.04%	274
2025 Q1	$3.24M	Buy	+91,611	New	+$3.72M	0.04%	270
2021 Q3	–	Sell	-21,853	Closed	-$694K	–	291
2021 Q2	$694K	Sell	21,853 -649	-3%	-$22.7K	0.01%	280
2021 Q1	$1.03M	Buy	+22,502	New	+$1.01M	0.01%	266

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Frontier Capital Management's RVMD Position: Q1 2026 in Review

Frontier Capital Management reduced its Revolution Medicines (RVMD) stake by 43% in Q1 2026, selling an estimated $18.9M and leaving 243,804 shares worth $23.7M. The position accounts for 0.24% of the portfolio, ranked #151.

Frontier Capital Management first reported a position in RVMD in Q1 2021 and has held it in 7 quarters since. The position peaked at $34.3M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Frontier Capital Management held 243,804 shares of Revolution Medicines worth $23.7M as of Q1 2026.
Frontier Capital Management sold 186,964 Revolution Medicines shares in Q1 2026, an estimated $18.9M.
Revolution Medicines made up 0.24% of Frontier Capital Management's portfolio in Q1 2026, its #151 holding.
Frontier Capital Management first reported a position in Revolution Medicines in Q1 2021 and has held it in 7 quarters since.
Frontier Capital Management's Revolution Medicines position peaked at $34.3M in Q4 2025.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Frontier Capital Management's 13F filing for Q1 2026, filed 15 May 2026.